SV
Smith-Van Vurst Andrew disclosed a 18.4% stake in BSEM
Smith-Van Vurst Andrew reported owning 18.4% of BioStem Technologies, Inc. (BSEM) (3,854,452 shares) in a Schedule 13G filed Nov 10, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 10, 2026
- Source
- Schedule 13G